FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Info Collection Extension for Social and Behavioral Research

Federal Register notice: FDA sends to OMB an information collection extension for Data to Support Social and Behavioral Research as Used by the Food a...

Medical Devices

Flowonix Larger Prometra II Infusion Pump OKd

FDA approves a Flowonix Medical PMA to market the Prometra II 40 mL Programmable Infusion Pump and its associated programmer software.

Human Drugs

Safety Alert on Cholesterol-lowering CholesLo

An FDA safety alert warns that CholesLo, a product promoted and sold for lowering cholesterol on various Web sites contains an undeclared drug ingredi...

FDA General

Trump Poised to Nominate Hahn to FDA: Report

The Washington Post says President Trump is ready to name MD Anderson Cancer Center chief operating officer Stephen Hahn to be FDA commissioner.

Medical Devices

Fresenius Gets Breakthrough on Hemodialysis System

FDA grants Fresenius Medical Care a breakthrough device designation for its new hemodialysis system that aims to prevent blood clotting without the us...

Medical Devices

FDA Wants Breast Implant Boxed Warning

FDA calls for a breast implant Boxed Warning and other labeling changes to help ensure that patients have information needed to make an informed decis...

Human Drugs

Postmarketing Study and Clinical Trial Guidance

FDA issues a draft guidance explaining its legal authority to require certain postmarketing studies and clinical trials for certain prescription drugs...

Medical Devices

Info Collection Extension for Device PMAs

Federal Register notice: FDA seeks comments on an information collection extension entitled Premarket Approval of Medical Devices.

Human Drugs

Info Collection Extension on Device Surveillance

Federal Register notice: FDA sends to OMB an information collection extension for Postmarket Surveillance of Medical Devices 21 CFR Part 822.

Human Drugs

FDA Biosimilar Testing Now Faster Than EMA

Harvard researchers say biosimilars are often approved by FDA before they are approved in Europe.